Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

Figure 2

Reverse cumulative curves for the ACWY-TT and the Men-PS groups for rSBA-MenA (A), rSBA-MenC (B), rSBA-MenW-135 (C), and rSBA-MenY (D.) ACWY-TT = group of participants who received one dose of MenACWY-TT at Month 0. Men-PS = group of participants who received one dose of the MenACWY polysaccharide vaccine at Month 0. PRE = pre-vaccination at Month 0; PI(M1) = post-vaccination at Month 1 (ATP immunogenicity cohort); PI(M12) = post-vaccination at Month 12 (ATP cohort for persistence Year 1).

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us